Literature DB >> 8201629

Can induced moods trigger drug-related responses in opiate abuse patients?

A R Childress1, R Ehrman, A T McLellan, J MacRae, M Natale, C P O'Brien.   

Abstract

This study investigated the ability of four hypnotically induced mood states (euphoria, depression, anxiety, and anger) to trigger craving and other drug-related conditioned responses in detoxified opiate abuse patients. Hypnotically induced depression produced significant increases in drug craving for opiates. Depression also tended to increase global self-ratings of opiate withdrawal. Other trends included increases in self-rated craving by induced anxiety and increases in withdrawal symptoms by induced anger. These results suggest that negative mood states, perhaps in the context of repeated attempts at self-medication, may become conditioned stimuli capable of triggering craving and other drug-related conditioned responses. The ability of depression to produce reliable effects in this particular patient group may reflect the high lifetime prevalence of depression diagnoses for this sample. The implications of these findings for therapeutic strategies are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8201629     DOI: 10.1016/0740-5472(94)90060-4

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  48 in total

1.  A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.

Authors:  Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

2.  Neurofeedback Effects on Evoked and Induced EEG Gamma Band Reactivity to Drug-related Cues in Cocaine Addiction.

Authors:  Timothy Horrell; Ayman El-Baz; Joshua Baruth; Allan Tasman; Guela Sokhadze; Christopher Stewart; Estate Sokhadze
Journal:  J Neurother       Date:  2010-07

3.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

4.  Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.

Authors:  Nurith Amitai; Jian Liu; Gery Schulteis
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

5.  Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal.

Authors:  Glenda C Harris; Gary Aston-Jones
Journal:  Behav Brain Res       Date:  2006-11-22       Impact factor: 3.332

Review 6.  Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction.

Authors:  Chiang-shan Ray Li; Rajita Sinha
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

7.  Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women.

Authors:  Helen C Fox; Rajita Sinha
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

8.  Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments.

Authors:  Hedy Kober; Judson A Brewer; Keri L Height; Rajita Sinha
Journal:  Neuroimage       Date:  2016-09-28       Impact factor: 6.556

9.  Self-regulatory depletion increases emotional reactivity in the amygdala.

Authors:  Dylan D Wagner; Todd F Heatherton
Journal:  Soc Cogn Affect Neurosci       Date:  2012-07-25       Impact factor: 3.436

10.  The moderating effect of parental illicit substance use disorders on the relation between adolescent depression and subsequent illicit substance use disorders.

Authors:  Stephanie M Gorka; Stewart A Shankman; John R Seeley; Peter M Lewinsohn
Journal:  Drug Alcohol Depend       Date:  2012-08-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.